Impact of modern antiviral therapy of chronic hepatitis B and C on clinical outcomes of liver disease

doi:10.3748/wjg.v27.i29.4831

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 29

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5260)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

395

WORD

183

HTML

2996

Figures (1-2)

526

Sum=4100

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

460

Download

700

Sum=1160

Aug 7, 2021 (publication date) through Dec 3, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Aug 7, 2021; 27(29): 4831-4845
Published online Aug 7, 2021. doi: 10.3748/wjg.v27.i29.4831

Full Size Figure Download Figure

Figure 1 Outcomes of hepatitis B after introduction of antiviral therapy. HCC: Hepatocellular carcinoma; HBV: Hepatitis B virus.

Citation: Khoo T, Lam D, Olynyk JK. Impact of modern antiviral therapy of chronic hepatitis B and C on clinical outcomes of liver disease. World J Gastroenterol 2021; 27(29): 4831-4845
URL: https://www.wjgnet.com/1007-9327/full/v27/i29/4831.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i29.4831